Aliqopa Approved for Follicular Lymphoma
THURSDAY, Sept. 14, 2017 -- Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults with relapsed follicular lymphoma who have received at least two prior treatments with certain other drugs.
Follicular...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news